CLOVER PARTNERS, L.P.
SEC file number 801-61598
· DALLAS, TX
This record was imported using its SEC file number. A CRD has not been verified in our database. Search SEC IAPD by firm name and confirm the entity before relying on this profile.
Regulatory AUM
$87.3M
Discretionary AUM
$87.3M
Employees
3
Clients
1
Firm
- Address
- 100 CRESCENT COURT
DALLAS, TX 75201 - Phone
- —
- Website
- —
- Disciplinary
- Unknown — verify on SEC IAPD
Sources
- Search SEC IAPD to verify this firm ↗
- Last refreshed Apr 28, 2026
Possible Form D name matches (not verified)
- Clover Fund Ltd High name-match confidence · CIK 2122846 · E9
- Clover Biopharmaceuticals, Ltd. High name-match confidence · CIK 1856491 · F4
- Clover Capital Cayman Fund Ltd. High name-match confidence · CIK 2099161 · CA
- Clover Capital Investments Fund LP High name-match confidence · CIK 2099162 · CA
- Clover Creekstone Venture, LLC High name-match confidence · CIK 2128561 · TX
- Clover Fast Food, Inc. High name-match confidence · CIK 1443931 · MA
- Cloverfield Funds, LP - I High name-match confidence · CIK 2063974 · WA
- Cloverfield Funds, LP - II High name-match confidence · CIK 2083952 · WA
- Cloverfield Funds, LP - III High name-match confidence · CIK 2132826 · WA
- Cloverfield Funds, LP OAI High name-match confidence · CIK 2104201 · WA
- Clover Gablepoint Venture, LLC High name-match confidence · CIK 2128562 · TX
- Clovergrove Drive Fund, LLC High name-match confidence · CIK 2139539 · IL
-
Clover Fast Food, Inc. · D · Jul 9, 2026$2.5M
-
Clovergrove Drive Fund, LLC · D · Jun 9, 2026$20M
-
Cloverfield Funds, LP - III · D · May 29, 2026$1.5M
-
Clover Biopharmaceuticals, Ltd. · D · Apr 29, 2026$3.6M
-
Clover Gablepoint Venture, LLC · D · Apr 17, 2026$3.1M
-
Clover Creekstone Venture, LLC · D · Apr 16, 2026$4.4M
-
Cloverfield Funds, LP OAI · D · Apr 14, 2026$2M
-
Clover Fund Ltd · D · Mar 26, 2026
-
Clover Capital Investments Fund LP · D · Dec 8, 2025
-
Clover Capital Cayman Fund Ltd. · D · Dec 8, 2025
-
Cloverfield Funds, LP - II · D · Nov 25, 2025$2M
-
Clover Biopharmaceuticals, Ltd. · D/A · Apr 28, 2025$904.9K
-
Cloverfield Funds, LP - I · D · Apr 8, 2025$2.5M